Description
Used in the treatment of:
- Metastatic colorectal cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Glioblastoma
Bevacizumab acts by neutralizing VEGF, restricting blood supply to the tumor and inhibiting its progression.
Support Email: info@biomedspecialitypharma.com
PRODUCT SPECIFICATION
Strength / Dose: 300 mg/12 mL per vial
Dosage Form: Concentrate for intravenous infusion
Packing Type: Glass vial with rubber stopper & aluminium seal
Treatment:
Used in the treatment of:
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Bevacizumab
Brand: Bryxta 300
Used in the treatment of:
PRODUCT SPECIFICATION
Strength / Dose: 100 mg per vial
Dosage Form: Injection for intravenous use
Packing Type: Glass vial with rubber stopper & aluminium seal, packed in carton
Treatment: Used in the treatment of malignant pleural mesothelioma and non-small cell lung cancer (NSCLC) (often in combination regimens)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Pemetrexed
Brand: Pempro
PRODUCT SPECIFICATION
Strength / Dose: 50 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of various malignancies (e.g., lymphomas, leukaemias, solid tumours) and sometimes in non-oncology immunosuppressive settings (as per approved uses)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Cyclophosphamide
Brand: Cycloxan
Our global distribution network and regulatory expertise enable us to deliver world-class pharmaceutical products that meet local market needs.
Address: DGS Sheetal Regalia, 209, Nensey Colony, Borivali East, Mumbai, Maharashtra 400066
Support mail: info@biomedspecialitypharma.com
Opening Hours: Monday – Saturday: 10.00am – 08.00pm